SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India informs about disclosure

11 Oct 2023 Evaluate

In terms of Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in view of organizational changes, Abbott India has informed that the Board of Directors has authorized: Vivek V Kamath, Managing Director and Sridhar Kadangode, Chief Financial Officer, severally, for determining materiality of an event or information for the purpose of disclosure and Sangeeta Shetty, Company Secretary, or in her absence, Sridhar Kadangode, Chief Financial Officer, severally, for making disclosure to the Stock Exchange and on Company’s website, as required under the Policy for Determination of Materiality of Event or Information for Disclosure.

The above information is a part of company’s filings submitted to BSE.

Abbott India Share Price

26370.90 -107.70 (-0.41%)
11-Jun-2026 11:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1792.20
Dr. Reddys Lab 1279.90
Cipla 1382.40
Zydus Lifesciences 1099.55
Lupin 2273.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×